These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 24706353)

  • 1. Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs.
    Carnota-Méndez P; Méndez-Vázquez C; Otero-Villar J; Saavedra-Pazos JA
    Eur J Ophthalmol; 2014; 24(5):771-7. PubMed ID: 24706353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP; Haji SA; Frenkel RE
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection.
    El Chehab H; Le Corre A; Agard E; Ract-Madoux G; Coste O; Dot C
    Eur J Ophthalmol; 2013; 23(3):277-83. PubMed ID: 23161177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension.
    Kim GN; Han YS; Chung IY; Seo SW; Park JM; Yoo JM
    Semin Ophthalmol; 2013 Mar; 28(2):61-7. PubMed ID: 23448557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
    El Chehab H; Le Corre A; Giraud JM; Ract-Madoux G; Swalduz B; Dot C
    J Fr Ophtalmol; 2012 Oct; 35(8):614-21. PubMed ID: 22832030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of brimonidine/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab.
    Theoulakis PE; Lepidas J; Petropoulos IK; Livieratou A; Brinkmann CK; Katsimpris JM
    Klin Monbl Augenheilkd; 2010 Apr; 227(4):280-4. PubMed ID: 20408074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial.
    Felfeli T; Hostovsky A; Trussart R; Yan P; Brent MH; Mandelcorn ED
    Br J Ophthalmol; 2019 Oct; 103(10):1388-1394. PubMed ID: 30573499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Topical application of hypotensive drugs for the prevention of intraocular pressure elevation after intravitreal injections of anti-VEGF drugs].
    Andreeva YS; Alkharki L; Shelankova AV; Budzinskaya MV
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):73-79. PubMed ID: 38739134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.
    Kim JE; Mantravadi AV; Hur EY; Covert DJ
    Am J Ophthalmol; 2008 Dec; 146(6):930-4.e1. PubMed ID: 18775528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case-control study.
    Song S; Yu XB; Dai H
    Indian J Ophthalmol; 2016 Oct; 64(10):762-766. PubMed ID: 27905340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the Honan intraocular pressure reducer to prevent vitreous reflux after intravitreal bevacizumab injection.
    Hong SW; Jee D
    Eur J Ophthalmol; 2012; 22(4):615-9. PubMed ID: 22562298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tunnelled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort.
    Knecht PB; Michels S; Sturm V; Bosch MM; Menke MN
    Retina; 2009 Sep; 29(8):1175-81. PubMed ID: 19734766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of blood pressure and intraocular pressure changes in hypertensive and nonhypertensive patients after intravitreal bevacizumab injection.
    Lee K; Yang H; Lim H; Lew HM
    Retina; 2009; 29(10):1409-17. PubMed ID: 19816242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections.
    Lemos V; Cabugueira A; Noronha M; Abegão Pinto L; Reina M; Branco J; Gomes T
    Ophthalmologica; 2015; 233(3-4):162-8. PubMed ID: 25791262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angled transscleral intravitreal injection: a crossover study.
    Mehta MC; Finger PT
    Eur J Ophthalmol; 2015; 25(2):173-6. PubMed ID: 25384968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major factors affecting intraocular pressure spike after intravitreal ranibizumab injection: Vitreous reflux and its amount.
    Uyar E; Ulas F; Sahin S; Celebi S
    Eur J Ophthalmol; 2019 Jul; 29(4):361-367. PubMed ID: 30947538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiglaucoma agents on short-term intraocular pressure fluctuations after intravitreal bevacizumab injections.
    Shoeibi N; Ghosi Z; Jafari H; Omidtabrizi A
    Int Ophthalmol; 2021 Mar; 41(3):1081-1090. PubMed ID: 33389369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and central corneal thickness.
    Omay E; Elgin U; Sen E; Yilmazbas P
    Int Ophthalmol; 2016 Oct; 36(5):665-70. PubMed ID: 26780098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients.
    Murray CD; Wood D; Allgar V; Walters G; Gale RP
    Eye (Lond); 2014 Oct; 28(10):1218-22. PubMed ID: 25081290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.
    Benz MS; Albini TA; Holz ER; Lakhanpal RR; Westfall AC; Iyer MN; Carvounis PE
    Ophthalmology; 2006 Jul; 113(7):1174-8. PubMed ID: 16647122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.